Featuring a slide presentation and related discussion from Dr Hanny Al-Samkari, including the following topics:
- Indications for initiation of treatment for patients with immune thrombocytopenia (ITP) and selection of first-line therapy (0:00)
- Treatment algorithm for ITP in the second line and beyond (7:47)
- Role of thrombopoietin receptor agonists and fostamatinib for second- and later-line treatment of ITP (14:21)
- Novel investigational approaches for the treatment of ITP — efgartigimod, rilzabrutinib and ianalumab (28:24)
CME information and select publications
Research To Practice | Oncology Videos